Plasma-Lyte 148 (ph 7.4) Solution for Infusion N/A Malta - English - Medicines Authority

plasma-lyte 148 (ph 7.4) solution for infusion n/a

baxter healthcare limited - sodium chloride; potassium chloride; magnesium chloride hexahydrate; sodium acetate trihydrate; sodium gluconate - solution for infusion - sodium chloride 5.26 g/l; potassium chloride 0.37 g/l; magnesium chloride hexahydrate 0.30 g/l; sodium acetate trihydrate 3.68 g/l; sodium gluconate 5.02 g/l - blood substitutes and perfusion solutions

20% SODIUM CHLORIDE INJECTION, BP SOLUTION Canada - English - Health Canada

20% sodium chloride injection, bp solution

baxter corporation - sodium chloride - solution - 20% - sodium chloride 20% - replacement preparations

Glucose 5% Sodium Chloride 0.45% New Zealand - English - Medsafe (Medicines Safety Authority)

glucose 5% sodium chloride 0.45%

baxter healthcare ltd - glucose 5%; sodium chloride 0.45% - solution for infusion - active: glucose 5% sodium chloride 0.45% excipient: water for injection - glucose and sodium chloride infusion solution is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of medication delivery where intravenous delivery is appropriate and the medicine is compatible with this solution.

Glucose 2.5% Sodium Chloride 0.45% New Zealand - English - Medsafe (Medicines Safety Authority)

glucose 2.5% sodium chloride 0.45%

baxter healthcare ltd - glucose 2.5%; sodium chloride 0.45% - solution for infusion - active: glucose 2.5% sodium chloride 0.45% - glucose and sodium chloride infusion solution is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of medication delivery where intravenous delivery is appropriate and the medicine is compatible with this solution.

Glucose 4% Sodium Chloride 0.18% New Zealand - English - Medsafe (Medicines Safety Authority)

glucose 4% sodium chloride 0.18%

baxter healthcare ltd - glucose 4%; sodium chloride 0.18% - solution for infusion - active: glucose 4% sodium chloride 0.18% - glucose and sodium chloride infusion solution is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of medication delivery where intravenous delivery is appropriate and the medicine is compatible with this solution.

Glucose 5% Sodium Chloride 0.9% New Zealand - English - Medsafe (Medicines Safety Authority)

glucose 5% sodium chloride 0.9%

baxter healthcare ltd - glucose 5%; sodium chloride 0.9% - solution for infusion - active: glucose 5% sodium chloride 0.9% - glucose and sodium chloride infusion solution is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of medication delivery where intravenous delivery is appropriate and the medicine is compatible with this solution.

Sodium Chloride Intravenous Infusion BP 0.9% w/v Malta - English - Medicines Authority

sodium chloride intravenous infusion bp 0.9% w/v

baxter healthcare limited caxton way, thetford, norfolk ip24 3se, united kingdom - sodium chloride - solution for infusion - sodium chloride 0.9 % (w/v) - blood substitutes and perfusion solutions

BAXTER Compound Sodium Lactate (Hartmann's Solution) 1000mL injection AHB2324 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter compound sodium lactate (hartmann's solution) 1000ml injection ahb2324

baxter healthcare pty ltd - potassium chloride, quantity: 400 mg/l; sodium lactate, quantity: 3.22 g/l; calcium chloride dihydrate, quantity: 270 mg/l; sodium chloride, quantity: 6 g/l - injection, solution - excipient ingredients: sodium hydroxide; lactic acid; water for injections - is indicated as a source of water and electrolytes. it is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. these solutions are indicated as methods of intravenous drug delivery, if the drugs are comparable with the solutions. this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

BAXTER Compound Sodium Lactate (Hartmann's Solution) 500mL injection AHB2323 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter compound sodium lactate (hartmann's solution) 500ml injection ahb2323

baxter healthcare pty ltd - calcium chloride dihydrate, quantity: 270 mg/l; sodium lactate, quantity: 3.22 g/l; potassium chloride, quantity: 400 mg/l; sodium chloride, quantity: 6 g/l - injection, solution - excipient ingredients: sodium hydroxide; water for injections - is indicated as a source of water and electrolytes. it is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. these solutions are indicated as methods of intravenous drug delivery, if the drugs are comparable with the solutions.

0.18%w/v Sodium Chloride and 4.0% w/v Glucose Intravenous Infusion BP, (Viaflo Container) Ireland - English - HPRA (Health Products Regulatory Authority)

0.18%w/v sodium chloride and 4.0% w/v glucose intravenous infusion bp, (viaflo container)

baxter holding b.v. - sodium chloride; anhydrous glucose - solution for infusion - 0.18/4 percent weight/volume - electrolyte solutions; electrolytes in combination with other drugs